Search clinical trials for: Durvalumab, Tremelimumab and ,FOLFOX
Total 2102 results
-
MedImmune LLCCompletedA Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid TumorsAdvanced Solid TumorsUnited States, United Kingdom
-
Institut Català d'OncologiaAstraZeneca; BioClever 2005 S.L.; VCN Biosciences, S.L.Active, not recruitingRecurrence | Head and Neck Neoplasms | Metastasis | Carcinoma, Squamous Cell of Head and NeckSpain
-
Muhammad FurqanRecruitingNon-small Cell Lung CancerUnited States
-
Washington University School of MedicineAstraZenecaRecruitingPrimary Central Nervous System LymphomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Van Andel Research InstituteActive, not recruitingUnresectable Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer AJCC v6 and v7 | Stage IV Pancreatic Cancer AJCC v6 and v7 | Recurrent Gallbladder Carcinoma | Unresectable Gallbladder Carcinoma | Recurrent Hepatocellular Carcinoma and other conditionsUnited States
-
Baptist Health South FloridaAstraZenecaTerminatedAdenocarcinoma of the PancreasUnited States
-
Centre Hospitalier Universitaire DijonRecruiting
-
UNICANCERNot yet recruitingColorectal Cancer | Digestive Cancer
-
SanofiCompleted
-
Abramson Cancer Center of the University of PennsylvaniaCompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
Fudan UniversityUnknown
-
Institut BergoniéEpizyme, Inc.; AstraZenecaRecruitingAdult Solid Tumor | Advanced Solid Tumor | Advanced Pancreatic Adenocarcinoma | Advanced Colorectal Carcinoma | Advanced Soft-tissue SarcomaFrance
-
Pharmacyclics LLC.AstraZeneca; Janssen Research & Development, LLCCompletedFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States
-
Centre Leon BerardCompletedFRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel (FRAIL-IMMUNE)Squamous Cell Carcinoma of the Head and NeckFrance
-
Sun Yat-sen UniversityCompletedHepatocellular CarcinomaChina
-
Centre Hospitalier Universitaire DijonRecruitingLocally Advanced or Metastatic Small Bowel AdenocarcinomaFrance
-
MedImmune LLCCompletedRecurrent or Metastatic Solid TumorsUnited States, Australia
-
Fudan UniversityCompletedEsophageal Squamous Cell Carcinoma
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Sky FoundationActive, not recruitingPancreatic Adenocarcinoma | Borderline Resectable Adenocarcinoma of the Head of the PancreaseUnited States, Canada
-
Dong-A University HospitalTerminated
-
Bristol-Myers SquibbCompleted
-
Sun Yat-sen UniversityFirst People's Hospital of Foshan; Guangzhou No.12 People's HospitalCompleted
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...RecruitingBladder CarcinomaItaly
-
AstraZenecaActive, not recruitingGastrointestinal Neoplasms | Esophagogastric JunctionBelgium, Denmark, Spain, United Kingdom, Canada, United States, Taiwan, Turkey, France, Germany, Korea, Republic of, Brazil, Hungary, Japan, Peru, Poland, Russian Federation, Netherlands, Chile, Argentina
-
Zhonglin HaoBayerActive, not recruiting
-
Tiago BiachiUnknownEsophageal Squamous Cell CarcinomaBrazil
-
Marc de PerrotOzmosis Research Inc.Not yet recruitingNon-small Cell Lung Cancer (NSCLC) | Lung Cancer Patients
-
Australasian Gastro-Intestinal Trials GroupRecruitingOesophageal CancerAustralia, New Zealand
-
China Medical University, ChinaNot yet recruitingBiliary Tract CancerChina
-
Rutgers, The State University of New JerseyAdlai Nortye Biopharma Co., Ltd.Not yet recruitingLung Cancer Stage IIIUnited States
-
Canadian Cancer Trials GroupAstraZeneca; Cancer Research Institute, New York City; BioAtla, Inc.RecruitingOvarian CancerUnited States, Canada
-
Ajjai Alva, MDAstraZeneca; Big Ten Cancer Research ConsortiumActive, not recruitingKidney Cancer | Clear Cell Renal Cell Carcinoma | Advanced Kidney CancerUnited States
-
M.D. Anderson Cancer CenterAstraZeneca; MedImmune LLCWithdrawnMalignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma | Advanced Lung Cancer | Recurrent Nonsmall Cell Lung Cancer
-
AstraZenecaCompleted
-
Joon Oh ParkRecruitingMetastatic Pancreatic CancerKorea, Republic of
-
iOMEDICO AGAmgenCompletedMetastatic Colorectal Cancer | RAS Wild-typeGermany
-
Shanghai First Maternity and Infant HospitalUnknown
-
MultiVir, Inc.UnknownLymphoma | Solid TumorUnited States
-
Institut BergoniéAstraZeneca; PharmaMarWithdrawnSmall Cell Lung Cancer | Platinum-Sensitive Lung Small Cell Carcinoma | Extensive-stage Small-cell Lung CancerFrance
-
University Health Network, TorontoOICRNot yet recruitingNon-Small Cell Lung Cancer (NSCLC) | Clinical Staging T2b-3 N0-1 M0
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingNSCLC | Lung Cancer | Non-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | PD-L1 Gene Mutation | Non-small Cell Lung Cancer Stage IIIA | Non-small Cell Lung Cancer Stage IIUnited States
-
Michael HoppAstraZenecaRecruitingSmall Cell Lung Cancer Limited StageGermany
-
Seoul National University HospitalCompletedHepatocellular CarcinomaKorea, Republic of
-
Centre Leon BerardAstraZeneca; PlexxikonCompletedColorectal Cancer | Pancreatic Cancer | Metastatic Cancer | Advanced CancerFrance
-
Insel Gruppe AG, University Hospital BernSwiss Cancer LeagueNot yet recruiting
-
Federation Francophone de Cancerologie DigestiveCompleted
-
Ohio State UniversityOsato Research InstituteCompleted
-
Second Affiliated Hospital, School of Medicine,...Completed
-
University of Texas Southwestern Medical CenterApexigen America, Inc.Active, not recruitingLocally Advanced Rectal AdenocarcinomaUnited States
-
Federation Francophone de Cancerologie DigestiveAmgenActive, not recruitingMetastatic Colorectal CancerFrance, Martinique